Anzeige
Mehr »
Login
Freitag, 10.05.2024 Börsentäglich über 12.000 News von 688 internationalen Medien
Innocan Pharma News: Unfassbare Studie - LPT-Therapie bewahrt Patient vor dem Tod!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A0LD76 | ISIN: FR0004174233 | Ticker-Symbol: 830
Frankfurt
10.05.24
08:10 Uhr
16,550 Euro
0,000
0,00 %
Branche
Dienstleistungen
Aktienmarkt
Sonstige
1-Jahres-Chart
BILENDI SA Chart 1 Jahr
5-Tage-Chart
BILENDI SA 5-Tage-Chart
RealtimeGeldBriefZeit
16,50017,05019:10
Dow Jones News
333 Leser
Artikel bewerten:
(2)

BILENDI: Revenues for 3rd quarter 2023 up +1.8% (+2.0% at constant exchange rates)

DJ BILENDI: Revenues for 3rd quarter 2023 up +1.8% (+2.0% at constant exchange rates)

BILENDI 
BILENDI: Revenues for 3rd quarter 2023 up +1.8% (+2.0% at constant exchange rates) 
08-Nov-2023 / 17:47 CET/CEST 
Dissemination of a French Regulatory News, transmitted by EQS Group. 
The issuer is solely responsible for the content of this announcement. 
=---------------------------------------------------------------------------------------------------------------------- 
 
 
Revenues for 3rd quarter 2023 
up +1.8% (+2.0% at constant exchange rates) 
 
 
Paris, 8 November, 2023 - Bilendi, a European leader in research technology and data, announces the publication of its 
revenues for the third quarter of 2023 and for the first nine months of 2023. 
 
 
              Q3            9M 
In MEUR, (unaudited figures) 2022 2023 VAR  At cer  2022 2023 VAR  At cer 
France           2,6 2,9 +12,0% +12,0%  9,3 9,7 +3,7% +3,7% 
International        11,4 11,4 -0,5% -0,2%  34,0 34,1 +0,4% +1,5% 
Total            14,0 14,2 +1,8% +2,0%  43,3 43,8 +1,1% +2,0% 

In the third quarter of 2023, Bilendi recorded consolidated revenues of EUR14.2 million, an increase of +1,8%. At constant exchange rates, growth was +2,0%.

Outside France (amounting to 80% of sales), Bilendi recorded stable revenues of EUR11.4 million, despite the adverse inflationary and macro-economic environment currently affecting the economic climate. The United Kingdom, the Nordic countries and Italy recorded the most significant growth in Q3.

In France (20% of sales), Bilendi recorded revenues growth of +12.0% to EUR2.9 million, accelerating sharply after a second quarter already up +5.4%.

Over the first nine months, Bilendi posted revenues of EUR43.8 million, up +1.1% (+2.0% at constant exchange rates). Despite continuing variations in monthly sales, linked to the current uncertain environment, Bilendi has maintained a good level of business resilience, driven by it's strategy focussed on the quality of its data, combined with technological and product innovation and its ability to deploy world-scale projects such as the research project for Harvard and Zurich Universities.

In Q3 2023, Bilendi was active in terms of technological and product innovations

Launch in June 2023 of a new version of the Bilendi Discuss platform, integrating A.I. and specifically ChatGPT

In June, Bilendi announced the launch of a new version of Bilendi Discuss, equipped with numerous new features and powered by both ChatGPT and its in-house AI. This new version meets the requirements of the market research industry and is adapted to the needs of researchers looking for a fluid and intuitive tool.

Launch in September 2023 of an innovative new "Niche Sampling" solution to survey niche audiences worldwide

During the third quarter, Bilendi announced a new "Niche Sampling" offering, enabling it to highly target audiences that represent a very small proportion of the population and cannot efficiently be addressed by panels.

Global TISP project conducted for the universities of Harvard and Zurich.

Bilendi has positioned itself in a market segment in which very few players worldwide have the relevant expertise. In particular, it offers services and technologies to manage surveys taking place simultaneously in a very large number of countries (up to 70) and in every language.

This expertise was recognised by the Market Research Society in London, which awarded Bilendi in the category of "Best Data Collection Solution for Quantitative Research" for the "Trust in Science and Science-related Populism" (TISP) project carried out in 68 countries, representing 79% of the world's population, for the universities of Harvard and Zurich.

In H2 2023, Bilendi expects growth and operating profitability to be higher than in H1 2023

On the strength of this 3rd quarter growth, Bilendi is confident of achieving in the second half of 2023:

- sales growth exceeding that of H1 2023;

- an improvement in operating profitability compared with H1 2023.

Objectives reaffirmed for 2026

Bilendi is reaffirming its aggressive growth strategy, combining organic development and targeted acquisitions, with the aim of achieving sales of EUR100 million by 2026, and EBITDA of 20% to 25% of sales, i.e., EUR20 to EUR25 million.

Next publication: 2023 revenues, February 27, 2024 (after market close)

About Bilendi

At a time when the volume, variety and speed of data transmitted and exchanged are increasing exponentially, Bilendi provides an innovative technological response to data collection, management and enhancement. Bilendi is thus positioned at the heart of data collection for two market segments: Technologies & Services for Market Research and Technologies & Services for Customer Engagement and Loyalty.

The Group has an international reach, with operations in 13 countries: France, the UK, Germany, Italy, Belgium, Spain, Sweden, Finland, Denmark, Switzerland, the Netherlands, Morocco, Mauritius Island. The Group has also business activity in Austria and Norway.

In 2021, Bilendi takes another major step in its development with the acquisition of Respondi, making it one of Europe's leading players in market research technology and data. In 2023, Bilendi launches Bilendi Discuss, an innovative new platform integrating AI functionalities, based on ChatGPT - a further demonstration of the Group's ability to position itself at the forefront of its market by offering its customers today's most advanced technologies and services.

Bilendi posted sales of EUR61.5 million in 2022, up +39.5%, of which +6.3% on a pro-forma basis.

The group is listed on Euronext Growth Paris.

ISIN code: FR0004174233 - Mnemo code: ALBLD - PEA PME eligible.

www.bilendi.com

Contacts

Bilendi 
Marc Bidou - Chairman and CEO 
Phone: +331 44 88 60 30 
m.bidou@bilendi.com 
 
ACTIFIN 
Analysts & Investors Relations     Press Relations 
 Nicolas Lin/ Alexandre Commerot   Isabelle Dray 
 nlin/acommerot@actifin.fr      idray@actifin.fr 
Phone: +331 56 88 11 11        Phone: +331 56 88 11 29 
 

-----------------------------------------------------------------------------------------------------------------------

Regulatory filing PDF file File: Revenues for 3rd quarter 2023 up +1.8% (+2.0% at constant exchange rates)

=---------------------------------------------------- 
Language:    English 
Company:     BILENDI 
         4 rue de Ventadour 
         75001 PARIS 
         France 
E-mail:     contact.fr@bilendi.com 
Internet:    www.bilendi.com 
ISIN:      FR0004174233 
Euronext Ticker: ALBLD 
AMF Category:  Inside information / Other releases 
EQS News ID:   1768771 
 
End of Announcement EQS News Service 
=------------------------------------------------------------------------------------ 

1768771 08-Nov-2023 CET/CEST

Image link: https://eqs-cockpit.com/cgi-bin/fncls.ssp?fn=show_t_gif&application_id=1768771&application_name=news

(END) Dow Jones Newswires

November 08, 2023 11:48 ET (16:48 GMT)

Lithium vs. Palladium - Ist das die Chance des Jahrzehnts?
Sichern Sie sich den kostenlosen PDF-Report! So können Sie vom Boom der Rohstoffe profitieren.
Hier klicken
© 2023 Dow Jones News
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.